The meaning of FACTOR V LEIDEN is a point mutation producing an abnormal version of factor V that is resistant to inactivation and causes prolonged clotting of blood.
Factor V Leiden 第五凝血因子；莱登第五因子 第五凝血因子 检验第五凝血因子(Factor V leiden)上的G1691A突变：造成容易产生血栓的体质(血栓病, thrombophilia)。北美洲有 5% 的人遗传有莱登第五因子 ( Factor V Leiden )﹐影响凝血功能。 年长﹑肥胖﹑抽烟﹐与及曾经出现过静脉栓塞症状的人士﹐再次...
(redirected fromFactor V Leiden mutation) Thesaurus Medical Legal Acronyms Encyclopedia mu·ta·tion (myo͞o-tā′shən) n. 1.The act or process of being altered or changed. 2.An alteration or change, as in nature, form, or quality. ...
Synonyms for Factor V Leiden mutation in Free Thesaurus. Antonyms for Factor V Leiden mutation. 34 synonyms for mutation: anomaly, variation, deviant, freak of nature, change, variation, evolution, transformation, modification, alteration, deviation...
WU Jingsheng,GU Jianmin,XU Jun,WANG Jian,SUN Ziming,MD Smirnov JH Morrissey and N Esmon.Factor V Leiden mutation in one family of Chinese origin. 中华医学杂志(英文版) . 2001吴竞生,汪建,孙自敏,等.Factor V Leiden mutation in one family of Chinese origin[J].中华医学杂志(英文版),2001,...
Factor V (Leiden), Mutation Analysis CPT Code:81241 Order Code:1089 ABN Requirement:No Specimen: Whole Blood Volume: 5.0 mL Minimum Volume: 3.0 mL Container:EDTA (lavender-top) (preferred) EDTA (royal blue-top) Sodium heparin (green-top) ACD solution A (yellow-top) ACD solution B (...
遗传阻断导读:Factor V Leiden易栓症是一种儿科疾病。佳学基因对Factor V Leiden易栓症的发生进行了基因解码,并将之收入《人的基因序列变化与人体疾病表征》中,便于医生选择和使用,进行Factor V Leiden易栓症遗传阻断,也便于患者更好地进行治疗和健康管理。
THE LEIDEN MUTATION OF THE FACTOR V GENE IN PREECLAMPSIA AND ECLAMPSIA 研究目的:以分子遺傳研究, 探討第五因子基因(Factor V gene)之來登突變 (Leiden mutation)與重度子癇前症/子癇症的相關.研究方法: 收集 105 位重度子癇前症/子癇症的... FM Chang 被引量: 0发表: 0年 The factor V Leiden ...
Factor V Leiden Mutation: What Is It? What Are the Implications for Cl inical Practice? American Journal for Nurse PractitionersFoster, Christine
Factor V Leiden mutation was detected in six patients (11.3%), heterozygous in all. The frequency of this mutation was statistically higher in group 1 (6/31, 19.3%) than in group 2 (0/22; P = 0.035). Within aPL-negative SNS, the comparison of patients with versus without factor V ...